Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
InhaleRx Limited ( (AU:IRX) ) just unveiled an update.
InhaleRx Limited reported its cash flow statement for the quarter ending December 31, 2024. The company experienced a net cash outflow from operating activities amounting to $97,000 for the quarter, primarily due to expenses in research and development, product manufacturing, and staff costs. However, government grants and tax incentives provided a significant boost. In terms of financing activities, the company secured $174,000 from the issuance of convertible debt securities, although it had to repay $546,000 in borrowings, leading to a net cash inflow of $117,000 for the period.
More about InhaleRx Limited
YTD Price Performance: -37.50%
Average Trading Volume: 149,559
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: A$5.34M
For detailed information about IRX stock, go to TipRanks’ Stock Analysis page.